Christoph Rentsch

Christoph Rentsch, Managing Partner Corporate Finance and Strategy at Ganda Business Solutions Ltd. is an active investor based in Switzerland. This profile covers what Christoph Rentsch backs, at which stage, and how founders can reach out in 2026.

Mr. Christoph Rentsch is a Co-Founder of TargImmune Therapeutics. He served as Partner, Private Equity at Independent Capital Group. He is an Angel Investor. He served as Chief Financial Officer & Member of the Board at ACM Biosciences. He serves as Executive Director and Board Member at TargImmune Therapeutics. He served as the Chief Financial Officer at Santhera Pharmaceuticals. He served as a Board Member at Cellestia Biotech. He is an Angel Investor. He served as the Chief Financial Officer of Polyphor. Prior to joining Polyphor, he was a partner of Caperis Ltd, an investment advisory and management firm. Previously he worked in various senior management functions for the Alusuisse-Lonza Group both in Switzerland and in the US (NY and PA) and as an associate in the equity capital markets group of Credit Suisse. He is an expert in private and public funding markets and an executive corporate finance leader with more than 25 years of experience in the life science field. He started his career in investment banking and worked in senior management functions for the Alusuisse-Lonza Group both in Switzerland and in the USA. In 1994 he returned to Switzerland to join Roche as Head of Group Funding and Capital Markets, taking responsibility for worldwide finance transactions. In 2004 he became managing partner of Caperis Ltd, a life science investment management firm, and was CFO of both Polyphor, and most recently, Santhera Pharmaceuticals, where he played a key role in realigning the company's strategic focus. Since 2020